HAWTHORNE, N.Y., Feb 12, 2003 (BUSINESS WIRE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq/NMS: TARO) intends to report financial results for the fourth quarter and full year ended December 31, 2002 prior to the Nasdaq market opening on Thursday, February 20, 2003.

The Company will conduct a conference call to discuss the results on the same day at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time).

The conference call will be hosted by Barrie Levitt, M.D., Chairman of the Company, who will review the quarter and the year along with Kevin Connelly, Chief Financial Officer, and Daniel Saks, Vice President, Corporate Affairs. The call will be available live via the Internet by accessing www.taro.com.

Online and telephone replays of the call will be available from approximately 1:00 p.m. on February 20th through February 28, 2003. The online replay can be accessed at www.taro.com. The telephone replay can be heard by dialing 1-800-428-6051 (domestic U.S.) or +973-709-2089 (international) and entering the passcode 286224 when prompted.

Taro is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

For more information on Taro, please visit www.taro.com.

CONTACT:          Taro Pharmaceutical Industries Ltd.
                  Daniel Saks 
                  Vice President, Corporate Affairs
                  914/345-9000 ext. 208
                  or
                  Kevin Connelly
                  Chief Financial Officer
                  914/345-9000 ext. 338

Copyright (C) 2003 Business Wire.  All rights reserved.